COVID-19
Finally, some good news on the COVID-19 front: several vaccines, all developed in record time, were being rolled out in a number of countries. While a huge step forward in bringing the pandemic under control, it comes at a time when, globally, more people are being infected with the coronavirus, and more people are dying from it than at any previous point in the pandemic. There is a long way to go before victory can be declared.
The local view
As was widely anticipated, the RBA cut the cash rate target by 0.15% to 0.1% in November. While welcomed by borrowers the cut put additional pressure on net savers by making it even harder to find low-risk income yielding investments. Some are turning to peer-to-peer lending platforms, or even high yielding shares, which may partly explain the strong recent performance of the ASX.
The official unemployment rate in November was 6.8%, the same as in August. However, using a different methodology, Roy Morgan calculated unemployment to be 11.9% in November, with a further 9.1% under-employed. While hardly cause for celebration, this was the first time since the pandemic began that both figures showed a month-on-month drop.
Property also received a boost. CoreLogic reported that dwellings rose in value by 0.4% in October and 0.8% in November. From March to October property fell just 1.7%, revealing the market to be more resilient than many anticipated.
And according to the Australian Bureau of Statistics, Santa stopped at 8.9 million households in Australia this Christmas.
The world stage
The US election delivered a change of president, with markets responding positively as the result became clear. As the year came to a close, a sigh of relief was heard from millions as the US Congress approved a coronavirus relief package worth $US892 billion ($1.18
trillion). The package includes $US600 payments to most Americans.
And finally, after years of negotiation and with just days to spare, the UK and EU managed to agree on a BREXIT trade deal. While it will keep the goods flowing between the UK and Europe, the agreement doesn’t cover the huge services sector. More talks, anyone?
The markets
It was a good quarter on the markets with the main global and US indices zooming past pre-COVID-19 levels. The MSCI AllCountry World Equity Index rose 13.4%. The Australian market followed suit, with the S&P/ASX200 rising 13.3%. However, the Aussie market has yet to return to its February high. In the US the S&P500 rose 11% and tech stocks continued to attract buyers with the NASDAQ up 15.5%. The A$ gained strength rising 8.2% against the greenback. While partly due to a weakening of the US$, the A$ was also up 2% against the British Pound, 3.4% against the Euro and 5.6% against the Yen.
The outlook
Beyond direct health effects, much of COVID-19’s economic impacts have been due to fear. It will take many months, but as vaccines are rolled out and provided they bring the pandemic under control much of that fear will dissipate. As it does, economic activity should pick up strongly.
Less likely to see any positive developments in the immediate future is the tense relationship between Australia and China. Australian coal miners, winemakers and barley growers will continue to bear the brunt of the dispute. Fortunately, China is still highly dependent
on Australian iron ore, the price of which has soared by 78% since the start of the year.
Sources:
- The Australian Bureau of Statistics
- Peer to peer lending
- Unemployment down sharply to 11.9% in November as lockdown finally ends in Victoria – lowest since early March
- Why didn’t the Australian housing market crash?
- CoreLogic November home value indices: Dwelling values rise across every capital city and rest-of-state region
You might also like
If you liked this quarterly review, you might be interested to know that we share useful thoughts and information like this in our monthly financial insights email. You can subscribe to that email here. All subscribers receive a copy of our e-book: The 5 Key Pillars of Financial Independence.
General Advice Disclaimer
This article contains general advice only, which has been prepared without taking into account the objectives, financial situation or needs of any person. You should, therefore, consider the appropriateness of the information in light of your own objectives, financial situation or needs and read all relevant Product Disclosure Statements before acting on the information. Whilst every care has been taken to ensure the accuracy of the material, Paradigm Strategic Planning or Sentry Advice Pty Ltd will not bear responsibility or liability for any action taken by any person, persons or organisation on the purported basis of information contained herein. Without limiting the generality of the foregoing, no person, persons or organisation should invest monies or take action on reliance of the material contained herein but instead should satisfy themselves independently of the appropriateness of such action.
Paradigm Strategic Planning Pty Ltd is an Authorised Representative of Sentry Advice Pty Ltd AFSL 227748